Weekly Tech+Bio Highlights #2

ALSO: Success in One of the 2024’s Most Anticipated Clinical Trials; New AI-Docking Engine Goes Open-source; 2024 State of CRISPR Clinical Trials; AlfaFold 3 is Great, But Use With Care

Hi! I am Andrii Buvailo, and this is my weekly newsletter, ‘Where Tech Meets Bio,’ where I talk about technologies, breakthroughs, and great companies moving the biopharma industry forward.

If you've received it, then you either subscribed or someone forwarded it to you. If the latter is the case, subscribe by pressing this button:

Now, let’s get to this…